Skip to main content

Table 1 Baseline characteristics of patients by miRNA assessment set

From: Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer

  TCGACOAD test cohort Independent validation cohort
  (n = 240) (n = 60)
Gender
 Male 132 38
 Female 108 22
Age
 60 years or younger 82 22
 Older than 60 years 158 38
TNM stage
 I 39 10
 II 93 15
 III 75 28
 IV 33 7
Pathologic M stage
 M0 207 53
 M1 33 7
Nodes count
 12 or more 189 19
 Less than 12 51 41
Lymphatic invasion
 Absent 166 25
 Present 74 35
Vascular Invasion
 Absent 193 47
 Present 47 13
Follow-up time (months)
 Median 13.367 33
 Range (0.067–141.1) (4.0–57.0)
Preoperative serum CEA level
 <5 μg/mL 188 37
 ≥5 μg/mL 52 23
  1. Abbreviation:CEA = carcinoembryonicantigen